These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15216952)

  • 1. Safety evaluation of piperacillin/tazobactam in very low birth weight infants.
    Berger A; Kretzer V; Apfalter P; Rohrmeister K; Zaknun D; Pollak A
    J Chemother; 2004 Apr; 16(2):166-71. PubMed ID: 15216952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
    Tellado J; Woods GL; Gesser R; McCarroll K; Teppler H
    Surg Infect (Larchmt); 2002; 3(4):303-14. PubMed ID: 12697078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, safety, and tolerance of piperacillin/tazobactam compared to co-amoxiclav plus an aminoglycoside in the treatment of severe pneumonia.
    Speich R; Imhof E; Vogt M; Grossenbacher M; Zimmerli W
    Eur J Clin Microbiol Infect Dis; 1998 May; 17(5):313-7. PubMed ID: 9721959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.
    Solomkin JS; Yellin AE; Rotstein OD; Christou NV; Dellinger EP; Tellado JM; Malafaia O; Fernandez A; Choe KA; Carides A; Satishchandran V; Teppler H;
    Ann Surg; 2003 Feb; 237(2):235-45. PubMed ID: 12560782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperacillin-Tazobactam-induced Adverse Drug Events in Pediatric Patients on Outpatient Parenteral Antimicrobial Therapy.
    Yusef D; Gonzalez BE; Foster CB; Goldfarb J; Saracusa C; Worley S; Sabella C
    Pediatr Infect Dis J; 2017 Jan; 36(1):50-52. PubMed ID: 27749652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study.
    Réa-Neto A; Niederman M; Lobo SM; Schroeder E; Lee M; Kaniga K; Ketter N; Prokocimer P; Friedland I
    Curr Med Res Opin; 2008 Jul; 24(7):2113-26. PubMed ID: 18549664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation.
    Philpott-Howard J; Burroughs A; Fisher N; Hastings M; Kibbler C; Mutimer D; Patch D; Rolando N; Wade J; Wendon J; O'Grady J
    J Antimicrob Chemother; 2003 Dec; 52(6):993-1000. PubMed ID: 14585863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections.
    Patel GW; Patel N; Lat A; Trombley K; Enbawe S; Manor K; Smith R; Lodise TP
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):236-40. PubMed ID: 19500529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers.
    Harkless L; Boghossian J; Pollak R; Caputo W; Dana A; Gray S; Wu D
    Surg Infect (Larchmt); 2005; 6(1):27-40. PubMed ID: 15865549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of extended-infusion piperacillin-tazobactam: a retrospective analysis of critically ill patients.
    Lee GC; Liou H; Yee R; Quan CF; Neldner K
    Clin Ther; 2012 Dec; 34(12):2297-300. PubMed ID: 23195962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study.
    Yost RJ; Cappelletty DM;
    Pharmacotherapy; 2011 Aug; 31(8):767-75. PubMed ID: 21923603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiologic clearance following transition from standard infusion piperacillin-tazobactam to extended-infusion for persistent Gram-negative bacteremia and possible endocarditis: A case report and review of the literature.
    D'Agostino C; Rhodes NJ; Skoglund E; Roberts JA; Scheetz MH
    J Infect Chemother; 2015 Oct; 21(10):742-6. PubMed ID: 26143049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial Stewardship.
    Karino S; Kaye KS; Navalkele B; Nishan B; Salim M; Solanki S; Pervaiz A; Tashtoush N; Shaikh H; Koppula S; Martin ET; Mynatt RP; Murray KP; Rybak MJ; Pogue JM
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3743-50. PubMed ID: 27067325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a two-center, before and after study of piperacillin-tazobactam versus ampicillin and gentamicin as empiric therapy for suspected sepsis at birth in neonates ≤ 1500 g.
    Chong E; Reynolds J; Shaw J; Forur L; Delmore P; Uner H; Bloom BT; Gordon P
    J Perinatol; 2013 Jul; 33(7):529-32. PubMed ID: 23328923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in multiresistant nosocomial infections in neonates following substitution of ceftazidime with piperacillin/tazobactam in empiric antibiotic therapy.
    Flidel-Rimon O; Friedman S; Gradstein S; Bardenstein R; Shinwell ES
    Acta Paediatr; 2003 Oct; 92(10):1205-7. PubMed ID: 14632339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Population Pharmacokinetics and Electronic Health Records to Assess Piperacillin-Tazobactam Safety in Infants.
    Salerno S; Hornik CP; Cohen-Wolkowiez M; Smith PB; Ku LC; Kelly MS; Clark R; Gonzalez D;
    Pediatr Infect Dis J; 2017 Sep; 36(9):855-859. PubMed ID: 28410277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fever and Reversible Laboratory Abnormalities Associated with Prolonged Use of Piperacillin-Tazobactam in Children.
    Patel A; Mao KR; McNeil JC; Kaplan SL; Vallejo JG
    Pediatr Infect Dis J; 2015 Aug; 34(8):849-50. PubMed ID: 25961892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open, multicenter clinical trial of piperacillin/tazobactam in the treatment of pediatric patients with intra-abdominal infections.
    Arguedas A; Sifuentes-Osornio J; Loaiza C; Herrera M; Corrales JC; Mohs E
    J Chemother; 1996 Apr; 8(2):130-6. PubMed ID: 8708744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerability of ertapenem.
    Teppler H; Gesser RM; Friedland IR; Woods GL; Meibohm A; Herman G; Mistry G; Isaacs R
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii75-81. PubMed ID: 15150186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of piperacillin/tazobactam (in association with amikacin) in neonatal sepsis: efficacy and safety data.
    Flidel-Rimon O; Friedman S; Leibovitz E; Shinwell ES
    Scand J Infect Dis; 2006; 38(1):36-42. PubMed ID: 16338836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.